Cancer vaccine development gets complicated

Asher Mullard
Nature Reviews Drug Discovery · Springer Nature · 2026-11-13 · DOI: 10.1038/d41573-026-00181-8

Abstract

Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than answers about the future of cancer vaccines.

Read at publisher →

Similar articles